Share this page

ARCHIVED - Formative Evaluation of the Canadian HIV Vaccine Initiative

This page has been archived.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.

Note to Readers / Update

The Canadian HIV Vaccine Initiative (CHVI) formative evaluation was conducted to measure the progress of the first two years of the initiative (2007/08 and 2008/09). The data collection phase for the evaluation was completed in August 2009. Since that time, the CHVI has undergone substantial changes.

In July 2010, at the XVIII International AIDS Conference in Vienna, Austria, the Government of Canada and the Bill & Melinda Gates Foundation announced their renewed commitment of up to $139 million to implement the CHVI and to establish a new CHVI Research and Development Alliance. In December 2010, the Government of Canada announced the co-chairs of the Advisory Board that will oversee the renewed CHVI and the Research and Development Alliance. Additional information on these changes is presented in the CHVI Management Response and Action Plan.